News
The round will accelerate US2.AI’s global commercial and regulatory rollout SINGAPORE, 14 APRIL 2022: Us2.ai, the Singapore-based medtech developers of FDA- cleared AI software that, for the first time ever, fully automates a complete echocardiography (heart ultrasound) report, today announced it has raised US$15 million in a series A round led by IHH Healthcare and…
Read MoreAI Med feature of AI Champions
Read MoreA profile of Dr Carolyn Lam in Tattler Asia.
Read MoreAutomated interpretation of systolic and diastolic function on the echocardiogram: a multicohort study
Read MoreDr Lam recognized as pioneer with multiple highly-cited papers in top 1% for field and year
Read MoreAnnounced at the Forbes Asia #100 to Watch Webinar
Read MoreUs2.ai wins a Digital Technologies of Tomorrow challenge.
Read More“Opening up access to millions more people…”
Read More